Page last updated: 2024-08-23

tetradecanoylphorbol acetate and HTLV-I Infections

tetradecanoylphorbol acetate has been researched along with HTLV-I Infections in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's5 (83.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gallo, RC; Gessain, A; Lam, VH; Lunardi-Iskandar, Y1
Buckner, C; Hooper, WC; Lal, RB; Pardi, D; Rudolph, D1
Chieco-Bianchi, L; Forino, M; Majone, F; Saggioro, D; Turchetto, L1
Kawamura, K; Maruyama, K; Mochizuki, S; Tamayama, C1
Fukushima, T; Kawamura, K; Maruyama, K; Mochizuki, S1
Kadin, ME; Su, IJ1

Other Studies

6 other study(ies) available for tetradecanoylphorbol acetate and HTLV-I Infections

ArticleYear
Abnormal in vitro proliferation and differentiation of T cell colony-forming cells in patients with tropical spastic paraparesis/human T lymphocyte virus type I (HTLV-I)-associated myeloencephalopathy and healthy HTLV-I carriers.
    The Journal of experimental medicine, 1993, Mar-01, Volume: 177, Issue:3

    Topics: Carrier State; CD3 Complex; CD4 Antigens; CD4-Positive T-Lymphocytes; CD8 Antigens; Cell Differentiation; Cell Division; Cells, Cultured; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Interleukin-2; Paraparesis, Tropical Spastic; Phenotype; Stem Cells; T-Lymphocytes; Tetradecanoylphorbol Acetate

1993
Infection with human T-lymphotropic viruses leads to constitutive expression of leukemia inhibitory factor and interleukin-6.
    Blood, 1993, Apr-01, Volume: 81, Issue:7

    Topics: Cell Line; Deltaretrovirus Infections; Growth Inhibitors; HTLV-I Infections; HTLV-II Infections; Humans; Interleukin-6; Leukemia Inhibitory Factor; Lymphokines; Tetradecanoylphorbol Acetate

1993
Studies on the mechanisms of HTLV-I leukemogenesis.
    Leukemia, 1992, Volume: 6 Suppl 3

    Topics: Cell Transformation, Neoplastic; DNA Damage; Genes, pX; HTLV-I Infections; Humans; Leukemia, T-Cell; Methylation; Micronucleus Tests; Plasmids; Tetradecanoylphorbol Acetate; Transcription, Genetic; Transfection; Tumor Cells, Cultured

1992
Autonomous growth of human T-lymphotropic virus type I infected human lymphocytes treated with N-methyl-N'-nitro-N-nitrosoguanidine and ultraviolet rays.
    Journal of leukocyte biology, 1991, Volume: 50, Issue:4

    Topics: Cell Division; Cell Transformation, Viral; Cells, Cultured; Chromosomes; Combined Modality Therapy; DNA, Viral; Female; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Karyotyping; Lymphocytes; Male; Methylnitronitrosoguanidine; Tetradecanoylphorbol Acetate; Ultraviolet Rays

1991
Chromosome and gene rearrangements in immortalized human lymphocytes infected with human T-lymphotropic virus type I.
    Cancer research, 1990, Sep-01, Volume: 50, Issue:17 Suppl

    Topics: Cells, Cultured; Chromosome Aberrations; Gene Rearrangement, beta-Chain T-Cell Antigen Receptor; HTLV-I Infections; Humans; Lymphocytes; Tetradecanoylphorbol Acetate

1990
Expression of growth factor/receptor genes in postthymic T cell malignancies.
    The American journal of pathology, 1989, Volume: 135, Issue:3

    Topics: Blotting, Northern; Growth Substances; HTLV-I Infections; Humans; Immunohistochemistry; Leukemia-Lymphoma, Adult T-Cell; Lymphocyte Activation; Lymphoma; Receptors, Mitogen; T-Lymphocytes; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured

1989